Here, H2B Clustered Histone 12 (H2BC12) was investigated in GII and GIII glioma tissue, assessing biomarkers for gliomas, associations with clinical characteristics, prediction survival outcome values, and the involved biological pathways. This evidence concerns the gene H2BC12 and glioma.